FIELD: medicine; infectiology; therapy.
SUBSTANCE: invention relates to the field of medicine, namely to infectiology and therapy; it is intended for the treatment of a bacterial infection. A method for the treatment of a bacterial infection in a subject is carried out by parenteral administration of active ingredients. The specified active ingredients include: 2 grams of cefepime or its pharmaceutically acceptable salt, from 0.70 to 0.80 grams of arginine or its pharmaceutically acceptable salt per one gram of cefepime or its pharmaceutically acceptable salt, and 2 grams of tazobactam or its pharmaceutically acceptable salt. The specified ingredients are administered parenterally during a period of time of 90 minutes.
EFFECT: use of the invention allows for an increase in the efficiency of treatment of a bacterial infection without causing phlebitis.
4 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL COMPOSITIONS | 2017 |
|
RU2813568C2 |
| COMPOSITIONS CONTAINING ANTIBACTERIAL AGENT AND TAZOBACTAM | 2011 |
|
RU2593363C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBACTERIAL AGENTS | 2014 |
|
RU2702361C2 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND THEIR APPLICATION FOR BACTERIAL INFECTIONS TREATMENT | 2012 |
|
RU2636147C1 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2560846C1 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2578370C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
| 1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
| NITROGEN-CONTAINING COMPOUNDS AND APPLICATION THEREOF | 2012 |
|
RU2569307C1 |
